IP Library › Assignment 024380/0158
Patent Assignment
Reel/Frame 024380/0158

Change of Name

Recorded: 2010-05-13 Pages: 18
Assignor
HANALL PHARMACEUTICAL CO., LTD.
Executed: 2010-03-29
Assignee
HANALL BIOPHARMA CO., LTD.
400-1, SANGSEO-DONG, DAEDEOK-GU,, DAEJEON 306-120, SEOUL, KOREA, REPUBLIC OF
Covered Property (1)
High Throughput Directed Evolution by Rational Mutagenesis
Patent: 7,647,184 →
Application: 10/022,249 →
Publication: US 2003/0134351
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 22, 2002
From: VEGA, MANUEL; DRITTANTI, LILA
To: NAUTILUS BIOTECH S.A.
Reel/Frame 013130/0131 →
Assignment of Assignor's Interest Jul 31, 2009
From: NAUTILUS BIOTECH S.A.
To: HANALL PHARMACEUTICAL CO., LTD.
Reel/Frame 023039/0017 →
Corrective Assignment to Correct the Assignee's Country Previously Recorded on Reel 023039 Frame 0017. Assignor(S) Hereby Confirms the Assignee's Country Is: the Republic of Korea (South Korea). Sep 10, 2009
From: NAUTILUS BIOTECH S.A.
To: HANALL PHARMACEUTICAL CO., LTD.
Reel/Frame 023216/0342 →